| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |